Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA064949-03
Application #
2107709
Study Section
Special Emphasis Panel (SRC (72))
Project Start
1994-08-08
Project End
1998-05-31
Budget Start
1996-06-01
Budget End
1997-05-31
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Duke University
Department
Surgery
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Zennadi, R; Abdel-Wahab, Z; Seigler, H F et al. (2001) Generation of melanoma-specific, cytotoxic CD4(+) T helper 2 cells: requirement of both HLA-DR15 and Fas antigens on melanomas for their lysis by Th2 cells. Cell Immunol 210:96-105
Yang, S; Kittlesen, D; Slingluff Jr, C L et al. (2000) Dendritic cells infected with a vaccinia vector carrying the human gp100 gene simultaneously present multiple specificities and elicit high-affinity T cells reactive to multiple epitopes and restricted by HLA-A2 and -A3. J Immunol 164:4204-11
Yang, S; Vervaert, C E; Burch Jr, J et al. (1999) Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8(+) and CD4(+) T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity. Int J Cancer 83:532-40
Yang, S; Vervaert, C E; Seigler, H F et al. (1999) Tumor cells cotransduced with B7.1 and gamma-IFN induce effective rejection of established parental tumor. Gene Ther 6:253-62
Yang, S; Darrow, T L; Seigler, H F (1997) Generation of primary tumor-specific cytotoxic T lymphocytes from autologous and human lymphocyte antigen class I-matched allogeneic peripheral blood lymphocytes by B7 gene-modified melanoma cells. Cancer Res 57:1561-8
Yang, S; Darrow, T L; Vervaert, C E et al. (1997) Immunotherapeutic potential of tumor antigen-pulsed and unpulsed dendritic cells generated from murine bone marrow. Cell Immunol 179:84-95
Stidham, K R; Ricci, W M; Vervaert, C et al. (1996) Modulation of specific active immunization against murine melanoma using recombinant cytokines. Surg Oncol 5:221-9
Darrow, T L; Abdel-Wahab, Z; Quinn-Allen, M A et al. (1996) Recognition and lysis of human melanoma by a CD3+, CD4+, CD8- T-cell clone restricted by HLA-A2. Cell Immunol 172:52-9